Welcome to Inhalation Sciences
Inhalation Sciences Sweden AB (ISAB) is a drug development and pharmaceutical services company conducting research and development of inhalation drugs on a contract basis for the pharmaceutical industry.The Company is introducing a new patented development path for inhalation drugs and inhaler devices.
The business concept is to develop promising drug molecules and formulations, matching suitable inhalers leading to successful aerosol therapies.
The development strategy is based on creating early predictive, human pharmacokinetic- and dynamic data including early toxicology data. By integrating the drug development process with selection of inhaler specific characteristics, drug to patient performance can be validated.
The generated data enables poor performing new chemical entities and generic drug formulations to be discarded early on in the development process. Promising drug-inhaler projects can be advanced into the clinic at a much earlier stage than previously possible.
The risk of expensive late stage product attritions due to poor performance in the clinic, can be substantially reduced.
The company is also developing its own pipeline of inhalation drugs.